Modulation of nitric oxide synthase activity by Burantashi (pausinystalia yohimbe) extract in Wistar rats

Christabel A. Omogiade; Mathias Abiodun Emokpae

doi:10.51496/jogm.v6.341

Authors

Christabel A. Omogiade Department of Medical Laboratory Science, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Nigeria
Mathias Abiodun Emokpae Department of Medical Laboratory Science, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Nigeria

DOI:

https://doi.org/10.51496/jogm.v6.341

Keywords:

Pausinystalia yohimbe, Burantashi, nitric oxide synthase, nitric oxide, Wistar rat, erectile physiology, yohimbine

Abstract

Introduction: Yohimbine-containing herbs (pausinystalia yohimbe, ‘Burantashi’) are traditionally used as aphrodisiacs and may alter nitric oxide synthase (NOS) pathways. NOS is essential for nitric oxide (NO) generation, which facilitates penile smooth muscle relaxation and vasodilation.

Aim and objectives: To examine the impact of sildenafil and the methanolic stem-bark extract of pausinystalia yohimbe (Burantashi) on NOS mRNA expression in male Wistar rats. The goals were to: (1) give graded extract dosages for 28 days; (2) measure NOS gene expression using semi-quantitative densitometry and RT-PCR; and (3) compare expression between groups.

Materials and methods: For 28 days, 25 adult male Wistar rats (n = 5 per group) were given either Burantashi extract (50, 100, or 200 mg/kg), sildenafil (5 mg/kg), or distilled water (control). Following euthanasia, NOS PCR was performed using agarose gel electrophoresis, and blood/tissue RNA was collected and reverse-transcribed. Tukey’s post hoc test was used to analyse the results of a one-way analysis of variance (ANOVA).

Results: Comparing the Burantashi-treated groups to the control, semi-quantitative densitometry showed dose-dependent elevation of NOS mRNA; sildenafil induced a strong upregulation. One-way ANOVA F(4,20) p < 0.001; Tukey’s post hoc: sildenafil and 200 mg significantly higher versus control, p < 0.01) showed the following representative (reconstructed) fold-change in NOS expression (mean ± standard error of mean) normalised to control (1.00): control 1.00 ± 0.05, sildenafil 2.10 ± 0.12, Burantashi 50 mg/kg 1.25 ± 0.08, 100 mg/kg 1.78 ± 0.09, and 200 mg/kg 2.45 ± 0.11).

Conclusion: In male Wistar rats, burantashi methanolic extract dose-dependently increases NOS gene expression, indicating that increased NO production is a likely explanation for its traditional aphrodisiac usage. The source data showed no concurrent rise in serum testosterone. Quantifying functional NO generation, hemodynamic outcomes, and safety will require additional effort.

Metrics

Metrics Loading ...

References

1.

Porrill J, Rogers RR, Ballmann CG. Ergogenic and sympathomimetic effects of yohimbine: a review. Neurol Int 2024; 16(2): 199–210. doi: 10.3390/neurolint16020016

2.

Nowacka A, Śniegocka M, Śniegocki M, Ziółkowska E, Bożiłow D, Smuczyński W. Multifaced nature of yohimbine – a promising therapeutic potential or a risk? Int J Mol Sci 2024; 25(5): 2593. doi: 10.3390/ijms25052593 DOI: https://doi.org/10.3390/ijms25052593

3.

Odigie BI, Osula FO. Sub-acute hepatotoxicity of Pausinystalia yohimbe bark extract (Burantashi) in male albino rats (Rattus norvegicus). Niger J Gastroenterol Hepatol 2014; 6(2): 45–52.

4.

Isaiah D, Ma NT, Nnanna JC. Impact of herbal aphrodisiac Pausinystalia yohimbe (Burantashi) on the morphology of sperm cells in adult male Wistar rats and mice. Acta Sci Pharm Sci 2020; 4(8): 51–7. doi: 10.31080/ASPS.2020.04.0489 DOI: https://doi.org/10.31080/ASPS.2020.04.0489

5.

Burnett AL. The role of nitric oxide in erectile dysfunction: implications for medical therapy. J Clin Hypertens (Greenwich) 2006; 8(12 Suppl 4): 53–62. doi: 10.1111/j.1524-6175.2006.06064.x DOI: https://doi.org/10.1111/j.1524-6175.2006.06026.x

6.

Huang SA, Lie JD. Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction. P T 2013; 38(7): 407–19.

7.

Samidurai A, Xi L, Das A, Kukreja RC. Beyond erectile dysfunction: cGMP-specific phosphodiesterase 5 inhibitors for other clinical disorders. Annu Rev Pharmacol Toxicol 2022; 62: 159–88. doi: 10.1146/annurev-pharmtox-051120-105255

8.

Cunningham CW. Potential natural product phosphodiesterase inhibitors. PhD dissertation, University of Georgia, Athens, GA, 2013.

9.

Cinelli MA, Tocchetti CG, Agrawal N, Kass DA, Paolocci N, Silverman RB. Inducible nitric oxide synthase: regulation, structure, and inhibition. Med Res Rev 2020; 40(1): 158–89. doi: 10.1002/med.21599 DOI: https://doi.org/10.1002/med.21599

10.

Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87(1): 315–424. doi: 10.1152/physrev.00029.2006 DOI: https://doi.org/10.1152/physrev.00029.2006

11.

Riddell DR, Owen JS. Nitric oxide and platelet aggregation. Vitam Horm 1997; 57: 25–48. doi: 10.1016/S0083-6729(08)60633-3

12.

Reddy D, Glynn SA, Billiar TR, Wink DA, Chang CF. Targeting nitric oxide: say NO to metastasis. Clin Cancer Res 2022; 28(5): 833–41. doi: 10.1158/1078-0432.CCR-21-2578 DOI: https://doi.org/10.1158/1078-0432.CCR-21-2578

13.

Kavoussi PK, Smith RP, Oliver ER, Costabile RA, Steers WD, Brown-Steinke K, et al. S-nitrosylation of endothelial nitric oxide synthase impacts erectile function. Int J Impot Res 2018; 30(2): 88–94. doi: 10.1038/s41443-017-0005-7

14.

Lee YJ, Kim HY, Kim YS, Seol GH, Lee CM. Lancemaside A, a major triterpene saponin of Codonopsis lanceolata, enhances regulation of nitric oxide synthesis via eNOS activation. BMC Complement Altern Med 2019; 19(1): 73. doi: 10.1186/s12906-019-2484-4 DOI: https://doi.org/10.1186/s12906-019-2516-6

15.

Vilahur G, Padró T, Casaní L, Mendieta G, López JA, Streitenberger S, et al. Polyphenol-enriched diet prevents coronary endothelial dysfunction by activating the Akt/eNOS pathway. Rev Esp Cardiol (Engl Ed) 2014; 67(12): 1004–11. doi: 10.1016/j.rec.2014.04.014 DOI: https://doi.org/10.1016/j.rec.2014.04.014

16.

Xu Y, Zhang H, Bai X, Yuan J, Wang Y, Liu J, et al. Botanical drugs for treating erectile dysfunction: clinical evidence. Front Pharmacol 2023; 14: 1101949. doi: 10.3389/fphar.2023.1101949

17.

Renda CR, Leri F. The anxiogenic drug yohimbine is a reinforcer in male and female rats. Neuropsychopharmacology 2024; 49(5): 894–903. doi: 10.1038/s41386-023-01780-9

18.

Aydın N, Demir B, Akdağ A, Gökmen S, Sayaslan A, Bayraç AT, et al. Accelerated breeding strategies for biochemical marker-assisted backcross breeding and mapping population development in bread wheat (Triticum aestivum L.). Euphytica 2024; 220(5): 360. doi: 10.1007/s10681-024-03260-0

19.

Milićević N, Mazzaro N, Bruin C, Wils L, Brink JV, Asbroek AA, et al. Rev-Erbα and photoreceptor outer segments modulate the circadian clock in retinal pigment epithelial cells. Sci Rep 2019; 9(1): 19725. doi: 10.1038/s41598-019-56118-3

20.

Schmid KT, Höllbacher B, Cruceanu C, Böttcher Y, Lickert H, Binder EB, et al. scPower accelerates and optimizes the design of multi-sample single-cell transcriptomic studies. Nat Commun 2021; 12(1): 6623. doi: 10.1038/s41467-021-26832-6

21.

National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals. 8th ed. Washington, DC: National Academies Press; 2011. doi: 10.17226/12910 DOI: https://doi.org/10.17226/12910